Capital World Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,446,142
Closed -$86.3M 561
2022
Q2
$86.3M Sell
1,446,142
-1,319,651
-48% -$78.7M 0.02% 345
2022
Q1
$201M Sell
2,765,793
-1,051
-0% -$76.3K 0.03% 298
2021
Q4
$233M Sell
2,766,844
-17
-0% -$1.43K 0.04% 298
2021
Q3
$250M Sell
2,766,861
-44
-0% -$3.97K 0.04% 283
2021
Q2
$264M Hold
2,766,905
0.04% 282
2021
Q1
$315M Sell
2,766,905
-362,819
-12% -$41.3M 0.06% 245
2020
Q4
$433M Sell
3,129,724
-107,737
-3% -$14.9M 0.08% 214
2020
Q3
$266M Buy
3,237,461
+48
+0% +$3.95K 0.06% 244
2020
Q2
$253M Buy
3,237,413
+32
+0% +$2.5K 0.06% 229
2020
Q1
$144M Buy
3,237,381
+86
+0% +$3.82K 0.04% 253
2019
Q4
$138M Buy
3,237,295
+865,865
+37% +$37M 0.03% 282
2019
Q3
$101M Buy
2,371,430
+500,858
+27% +$21.4M 0.02% 292
2019
Q2
$119M Buy
1,870,572
+62,182
+3% +$3.95M 0.03% 285
2019
Q1
$125M Buy
1,808,390
+225,000
+14% +$15.6M 0.03% 279
2018
Q4
$68.8M Buy
1,583,390
+122,000
+8% +$5.3M 0.02% 318
2018
Q3
$112M Buy
1,461,390
+630,088
+76% +$48.1M 0.03% 301
2018
Q2
$63.9M Buy
831,302
+321,302
+63% +$24.7M 0.01% 345
2018
Q1
$26M Hold
510,000
0.01% 408
2017
Q4
$23.7M Buy
510,000
+105,000
+26% +$4.87M 0.01% 414
2017
Q3
$21.6M Buy
405,000
+195,000
+93% +$10.4M ﹤0.01% 421
2017
Q2
$13M Buy
210,000
+65,000
+45% +$4.04M ﹤0.01% 454
2017
Q1
$9.83M Buy
+145,000
New +$9.83M ﹤0.01% 461
2016
Q1
Sell
-70,000
Closed -$7.85M 515
2015
Q4
$7.85M Hold
70,000
﹤0.01% 490
2015
Q3
$6.74M Hold
70,000
﹤0.01% 489
2015
Q2
$7.17M Sell
70,000
-75,000
-52% -$7.68M ﹤0.01% 507
2015
Q1
$9M Sell
145,000
-216,987
-60% -$13.5M ﹤0.01% 497
2014
Q4
$15.9M Hold
361,987
﹤0.01% 458
2014
Q3
$20.5M Hold
361,987
0.01% 428
2014
Q2
$16.3M Hold
361,987
﹤0.01% 439
2014
Q1
$17.7M Buy
+361,987
New +$17.7M 0.01% 430